Etiology of multicystic dysplastic kidney (MCDK
INTRODUCTION

The etiology of multicystic dysplastic kidney (MCDK) is not well understood. While there are many kidneys with evidence of obstruction at the level of the renal pelvis, ureters, bladder, or urethra, there is another subset of patients with MCDKs in which there is no evidence of obstruction. These patients may have an isolated renal defect or other major malformations such as in Meckel-Gruber syndrome, polysplenia, shortrib syndrome, congenital heart disease, trisomies, etc.
Multicystic dysplastic kidney occurs in 1 out of 4300 live births [1] . [2] . Alterations in the regulatory genes such as paired box gene 2 (PAX2) [3] and the protooncogene B-cell lymphoma-2 (BCL-2) [4] 
Multicystic dysplasia involves the interaction betweeen the metanephric blastema and the ureteric bud. Multicystic dysplastic kidney is generally associated with an imbalance in the normal mesenchymal to epithelial transformation resulting in excessive fibrous tissue surrounding cystically dilated tubules and a decreased number of glomeruli. Transcription growth factor-beta (TGF-β) is important in the mesenchymal-to-epithelial transformation process involving the metanephric blastema and the ureteric bud
are associated with the formation of renal cysts. PAX2 is a transcription factor that is active in nephrogenesis, including condensing metanephric mesenchyme and in early epithelial structures derived from mesenchyme. PAX 2 is downregulated as the tubular epithelium matures. BCL-2 represses cell death by apoptosis; the later has been proven to be related to the development
METHOD
The autopsy files at our institution were searched for patients with MCDK Figure 1 .
The immunohistochemical profile is described as follows: TGF-β was negative in 10 out of 10 cases with MCDK associated with obstruction (Figure 2A) , while it was positive in the renal interstitium of five patients with syndromic nonobstructive MCDK ( Figure 2B ). TGF-β was negative in the two patients with nonsyndromic, nonobstructive MCDK. All fetuses and embryos were negative in the interstitium and in tubules and nephrogenic zone ( Figure 2C ). Regarding controls, TGF-β was uniformly negative in the interstitium, but it was focally positive in glomeruli ( Figure 2D ).
PAX2 depicted a nuclear staining in the dysplastic tubular epithelium and proximal tubules of all obstructive ( Figure 3A ) and nonobstructive MCDK's ( Figure 3B .) Likewise, the embryos and fetuses were all positive in the nephrogenic zone ( Figure 3C ). In controls with a gestational age of less than 36 weeks, there was active nephrogenesis Figure 4C) ; it was negative in the interstitium of normal kidneys but stained positive in some tubules ( Figure 4D -see  arrows) .
β-catenin showed a membranous staining of dysplastic tubular epithelium in 10 out of 10 cases with obstructive ( Figure 5A ) and in all seven patients with nonobstructive MCDKs ( Figure 5B ). The staining was even stronger in the nephrogenic zone of fetal and embryonal kidneys ( Figure 5C ) and controls ( Figure 5D ). Figure 6D ). Tables 1 and 2 
IGF-2 exhibited a strong membranous and cytoplasmic pattern in the dysplastic tubular epithelium of 9 out of 10 patients with obstructive MCDK (Figure 6A) and a weaker, albeit positive, staining in all seven cases with nonobstructive MCDKs (Figure 6B). It was positive in the nephrogenic zone of all fetal and embryonal kidneys (Figure 6C). Regarding normal controls, IGF-2 was positive (membranous and cytoplasmic) in the cortical tubular epithelium in 15 out of 17 patients (
Immunohistochemistry of MCDK With and Without Obstruction 
FIGURE 4 BCL2 expression. (A) Positive cytoplasmic staining in dysplastic tubular epithelium of obstructive MCDK. (B) Similar positivity in non-obstructive MCDK. (C) Positive in nephrogenic zone of fetal kidney. (D) Minimal expression in the tubules of normal control (arrows). 76 × 57 mm.
DISCUSSION
TGF-β is a secreted growth factor that is part of a family of proteins known as a transforming growth factor beta superfamily, which includes inhibins, activin, anti-mullerian hormone, bone morphogenetic protein, decapentaplegic, and Vg-1. TGF-β is involved in numerous cellular functions including proliferation and differentiation. It is also implicated in epithelial-to-mesenchymal transformation that is an important component of organogenesis. In-vitro studies showed TGF-β to cause mammalian epithelia and endothelia to develop mesenchymal characteristics. TGF-β is expressed during normal rodent nephrogenesis and is upregulated in the sheep model of fetal kidney obstruction [6]. These authors found immunoreactive TGF-β in the urine after experimental obstruction of ovine fetal lower urinary tract. In our study, there was no immunoreactivity for TGF-β in MCDKs associated with obstruction, while on the other hand, we found all cases of syndromic MCDK without evidence of obstruction to be immunoreactive for TGF-β (see
for clinical information).
It has been proven that stumpy mutant mice have a defect in ciliogenesis resulting in hydrocephalus and cystic renal disease resembling the human Meckel Gruber syndrome [7] . These [3] . In our study, we found that PAX2, consistent with being a transcriptional factor, is present within the nuclei of dysplastic tubular epithelium in MCDK cases and the nuclei of nondysplastic tubular epithelium of preterm controls. It is also present in the immature glomeruli within the nephrogenic zones of controls and fetal-embryonic cases. However as the gestational age of MCDK cases and controls increased, the intensity of immunostaining diminished. Immunostaining for PAX2 was negative in the mature glomeruli.
BCL-2 is a proto-oncogene originally associated with the t(12:18) chromosomal translocation, which is the cytogenetic hallmark of follicular lymphoma [4] . As a 
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